![Andy W. Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andy W. Smith
Corporate Officer/Principal chez
PharmaVentures Ltd.
Profil
Dr. Andy W.
Smith is a Portfolio Manager at AXA Investment Managers UK Ltd.
He joined AXA Framlington, the qualitative equity brand of AXA Investment Managers in April 2008 as Portfolio Manager within the healthcare team with specific responsibility for the AXA Framlington Biotech Fund.
Previously, he spent three years at SV Life Sciences where he was responsible for managing a global biotechnology investment fund.
From 2004 to 2005 he worked at Schroders as Director and Fund Manager, Global Equities.
Between 2002 and 2004 he worked within the Asset Management division of the 3i Group as Investment Manager and then Director.
From 1994 to 2000, he worked at SmithKline Beecham Pharmaceuticals & Consumer Healthcare as Project Manager, Dermatologicals (1994-1996), Assistant Director New Product Research (1996-1998) and Global Brand Manager, Bactroban & New Products (1998-2000).
From 1992 to 1994 Dr. Andy W.
Smith was a lecturer in Microbiology at UMDS Guy’s Hospital Medical School and from 1990 to 1992 Section Manager Microbiology Research at SmithKline Consumer Brands.
He started his career in 1985 as Senior Scientific Officer at ICI’s Plant Protection Division.
Dr. Andy W.
Smith has a PhD in Molecular Biology from the University of Nottingham (1990) and an MBA in International Marketing from the University of Greenwich (1996).
He graduated from North East London Polytechnic with a BSc (Hons.) in Applied Biology (Microbiology).
Postes actifs de Andy W. Smith
| Sociétés | Poste | Début |
|---|---|---|
PharmaVentures Ltd.
 PharmaVentures Ltd. Investment ManagersFinance Provides advising services on life sciences transactions | Corporate Officer/Principal | 05/10/2011 |
Anciens postes connus de Andy W. Smith
| Sociétés | Poste | Fin |
|---|---|---|
AXA Investment Managers UK Ltd.
 AXA Investment Managers UK Ltd. Investment ManagersFinance AXA IM-UK focuses on investment areas where they have a competitive edge within each asset class. They are organized in small investment teams dedicated to a specific instrument, sector, region or strategy. Each team is supported by a shared pool of fundamental research resources and empowered to make investment decisions. With fundamental research at the core of their process, their investment professionals seek out and develop sources of alpha across world markets. AXA IM-UK's research is organized along investment strategy, equity and fixed-income and is supported by proprietary quantitative resources and an extensive company visit program. | Analyst-Equity | 01/06/2010 |
AXA Framlington Investment Management Ltd.
 AXA Framlington Investment Management Ltd. Investment Trusts/Mutual FundsMiscellaneous AFIM is an active, bottom-up and GARP-oriented investment manager which utilizes a fundamental approach to select stocks, aiming to consistently deliver investment outperformance. Primarily an equity investment manager, the firm invests in companies which are expected to produce above-average earnings growth and dividends over a complete economic cycle. AFIM performs most of their research internally, and the investment team considers the quality of a company's management and financial position, the industry in which it operates and its competitive position, before making the investment decision. | Gestionnaire de Portefeuille-Actions | 01/06/2009 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Private Equity Investor | 29/02/2008 |
Schroder Investment Management Ltd.
 Schroder Investment Management Ltd. Investment ManagersFinance SIM is an active investment manager that utilizes a contrarian investment approach supported by fundamental, in-house research, regular company visits and their group's global network. Research is shared worldwide within the parent group and is organized in specialist teams, with local specialists contributing their expertise to global sector teams. The firm also utilizes their proprietary software, the Global Research Investment Database, to integrate and distribute in-house and external research, assisting investment managers in portfolio construction. They manage risk through another proprietary tool called Portfolio Risk Investment Strategy Manager (PRISM). | Gestionnaire de Portefeuille-Actions | 13/06/2005 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Schroder Investment Management Ltd.
Schroder Investment Management Ltd. Investment ManagersFinance SIM is an active investment manager that utilizes a contrarian investment approach supported by fundamental, in-house research, regular company visits and their group's global network. Research is shared worldwide within the parent group and is organized in specialist teams, with local specialists contributing their expertise to global sector teams. The firm also utilizes their proprietary software, the Global Research Investment Database, to integrate and distribute in-house and external research, assisting investment managers in portfolio construction. They manage risk through another proprietary tool called Portfolio Risk Investment Strategy Manager (PRISM). | Finance |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
PharmaVentures Ltd.
PharmaVentures Ltd. Investment ManagersFinance Provides advising services on life sciences transactions | Finance |
AXA Investment Managers UK Ltd.
AXA Investment Managers UK Ltd. Investment ManagersFinance AXA IM-UK focuses on investment areas where they have a competitive edge within each asset class. They are organized in small investment teams dedicated to a specific instrument, sector, region or strategy. Each team is supported by a shared pool of fundamental research resources and empowered to make investment decisions. With fundamental research at the core of their process, their investment professionals seek out and develop sources of alpha across world markets. AXA IM-UK's research is organized along investment strategy, equity and fixed-income and is supported by proprietary quantitative resources and an extensive company visit program. | Finance |
AXA Framlington Investment Management Ltd.
AXA Framlington Investment Management Ltd. Investment Trusts/Mutual FundsMiscellaneous AFIM is an active, bottom-up and GARP-oriented investment manager which utilizes a fundamental approach to select stocks, aiming to consistently deliver investment outperformance. Primarily an equity investment manager, the firm invests in companies which are expected to produce above-average earnings growth and dividends over a complete economic cycle. AFIM performs most of their research internally, and the investment team considers the quality of a company's management and financial position, the industry in which it operates and its competitive position, before making the investment decision. | Miscellaneous |
